Onyx Health wins new briefs with Newcells Biotech and HeartScan

Onyx Health has expanded its client roster over the last month after winning new contracts with Newcells Biotech and HeartScan.

Newcells Biotech – a provider of unique cell-based assays using induced pluripotent stem cells (iPSC) for the drug and chemical preclinical market – has hired the agency to strengthen its position in the drug discovery outsourcing sector.

The client is keen to take advantage of the growing demand for iPSCs as a means of reducing costs and improving the predictability of drug development, and position itself at the forefront of this market.

Meanwhile, HeartScan has appointed Onyx Health to help develop valuable insights into its customer needs, allowing the client to gain access to many of the stakeholders it needs to work with.

The firm offers expertise in echocardiography and sports screening, and is actively pursuing growth in the north-east of England and beyond.

Karen Winterhalter, director of Onyx Health, said: "Our knowledge of the healthcare market enables us to develop and implement sales and marketing strategies to help companies navigate the complexities of global healthcare markets, wherever they might be based."

With over 20 years of experience within the healthcare communications market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current healthcare communications roles we have available, you can search for the latest job roles, register your details, or contact the team today.